可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity[J]. Circulation, 2003, 107(23):2908-2913.
[2] Lau WC, Gurbel PA, Watkins PB, et al. Contribution of hepatic cytochrome P 450 3A4 metabolic activity to the phenomenon of clopidogrel resistance[J]. Circulation, 2004, 109(2):166-171.
[3] Soffer D, Moussa I, Harjai KJ, et al. Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: do we need more aggressive dosing regimens in unstable angina?[J]. Catheter Cardiovasc Interv, 2003, 59(1):21-25.
[4] Matetzky S, Shenkman B, Guetta V, et al. Clopidogrel resistanceis associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction[J]. Circulation, 2004, 109(25):3171-3175.